23 certified Labor Condition Applications on file with the U.S. Department of Labor, FY2021–FY2026.
Since September 2025, DOL's Project Firewall opens H-1B investigations without waiting for a complaint. These checkpoints come from Tulex Pharmaceuticals Inc.'s own public LCA filings (FY2024–FY2026) — the same records an investigator pulls first.
Next end date: 2026-12-27. Employing an H-1B worker past the LCA end date without a new certified LCA is a strict-liability violation — the replacement LCA must be certified before the I-129 extension is filed.
Level I is the entry-level prevailing-wage tier and the band DOL's Project Firewall reviews first for misclassification (senior duties filed at an entry-level wage). The national share is 17%.
Median offered wage is 7% above the DOL prevailing wage across 7 recent certified LCAs. Paying at the floor is lawful, but it invites the question of whether the wage level itself is right.
Each worksite needs its own 10-business-day LCA notice and a PAF record of that posting; a move to a new area of intended employment needs a new LCA before the worker starts there.
No additional recruitment or non-displacement attestations apply.
Public DOL disclosure data can lag actual filings by a quarter. Descriptive only — not legal advice.
Yes — Tulex Pharmaceuticals Inc. sponsors H-1B workers, with 23 certified LCAs on file (FY2021–FY2026), including 1 in FY2026. The median certified salary is $76,814 (P25 $76,814, P75 $93,000). With a 43% transfer share, this employer actively accepts H-1B transfers. 100% of its certified filings meet or exceed the prevailing wage.
Tulex Pharmaceuticals Inc. H-1B sponsorship at a glance, from public U.S. DOL LCA disclosure data (FY2021–FY2026).
Certified LCAs are a prerequisite to H-1B petitions, not visa approvals; one LCA can cover multiple workers. Descriptive only — not legal advice.
The shaded band is the middle half of certified salaries (P25–P75); the bar spans the lowest to highest certified salary.
Levels I–IV are DOL prevailing-wage experience tiers; 26% of filings are senior-level (III–IV).
| Fiscal year | Certified | Denied | Withdrawn | Total |
|---|---|---|---|---|
| FY2021 | 14 | 0 | 0 | 14 |
| FY2022 | 1 | 0 | 0 | 1 |
| FY2023 | 1 | 0 | 0 | 1 |
| FY2024 | 4 | 0 | 0 | 4 |
| FY2025 | 2 | 0 | 0 | 2 |
| FY2026 | 1 | 0 | 0 | 1 |
Case dispositions from the U.S. DOL OFLC disclosure files. Withdrawn are LCAs that were certified and later withdrawn by the employer; they still count toward Total.
| Job title | Salary | Level | Location | Filed | Status |
|---|---|---|---|---|---|
Principal Scientist (Chemist) I-200-25307-360008 | $115,000/yr | III | Cranbury, NJ | Nov 03, 2025 | Certified |
Principal Scientist I-200-25210-207052 | $115,000/yr | IV | Cranbury, NJ | Jul 29, 2025 | Certified |
Senior Chemist I-200-25190-162206 | $105,000/yr | III | Cranbury, NJ | Jul 09, 2025 | Certified |
Principal Scientist I, Product Development I-200-24254-326927 | $120,000/yr | IV | Cranbury, NJ | Sep 10, 2024 | Certified |
Senior Chemist (Analytical Group) I-200-24101-874086 | $96,000/yr | III | Cranbury, NJ | Apr 10, 2024 | Certified |
Chemist I-200-24082-824786 | $90,000/yr | II | Cranbury, NJ | Mar 22, 2024 | Certified |
Chemist I-200-23334-532622 | $90,000/yr | II | Cranbury, NJ | Nov 30, 2023 | Certified |
Principal Scientist (Chemist) I-200-23079-862014 | $105,000/yr | III | Cranbury, NJ | Mar 20, 2023 | Certified |
Sr. Scientist - Formulation I-200-22187-333947 | $85,000/yr | II | Cranbury, NJ | Jul 06, 2022 | Certified |
Formulation Scientist I-200-21235-537970 | $90,000/yr | II | Cranbury, NJ | Aug 23, 2021 | Certified |
Chemist I-200-21202-475214 | $70,000/yr | I | Cranbury, NJ | Jul 21, 2021 | Certified |
Accountant I-200-21174-421047 | $65,000/yr | I | Cranbury, NJ | Jun 23, 2021 | Certified |
Chemist I-200-21113-254514 | $65,000/yr | I | Cranbury, NJ | Apr 23, 2021 | Certified |
Chemist I-200-21091-191916 | $76,814/yr | II | Cranbury, NJ | Apr 01, 2021 | Certified |
Chemist II I-200-20344-944595 | $76,814/yr | II | Cranbury, NJ | Dec 09, 2020 | Certified |
Chemist II I-200-20344-946120 | $76,814/yr | II | Cranbury, NJ | Dec 09, 2020 | Certified |
Chemist I-200-20281-869695 | $76,814/yr | II | Cranbury, NJ | Oct 07, 2020 | Certified |
One row per LCA case (its latest version), from U.S. DOL OFLC disclosure data. Salaries are the offered wage, converted to a yearly figure. Certified LCAs are not visa approvals.
Worker positions by LCA filing purpose, summed across FY2021–FY2026 disclosure records.
Most active filing months: Dec and Jul — useful for timing transfer conversations.
Attestations from the employer's own LCA filings (Form ETA-9035), as disclosed by the U.S. DOL.
1 state · 1 city
The same DOL data on this page is what every H-1B sponsor must track for each worker. ElevateStaffing.ai automates it end-to-end:
Get the private PAF / LCA gap check for your own filings — free, one business day — then let ElevateStaffing.ai keep every LCA, PAF, I-9 and I-983 deadline audit-ready.
Get my private gap check →